⌘K

Login Start Free

Home/Filings/4/0001209191-19-040976

4//SEC Filing

Clemens Kevan 4

Accession 0001209191-19-040976

CIK 0001262104other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 3:31 PM ET

Size

5.4 KB

Accession

0001209191-19-040976

Insider Transaction Report

Form 4

Period: 2019-07-01

MEI Pharma, Inc.MEIP

Director

Transactions

Award
Stock Option (Right to Buy)
2019-07-01+40,000→ 40,000 total
Exercise: $2.52Exp: 2029-07-01→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The options will vest in equal monthly installments over twelve months.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

MEI Pharma, Inc.

CIK 0001262104

Entity typeother

Related Parties

1

filerCIK 0001316737

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 3:31 PM ET
Size: 5.4 KB

View on SEC.gov